209 related articles for article (PubMed ID: 38691886)
1. Structure-activity relationship in NOD2 agonistic muramyl dipeptides.
Kamboj A; Patil MT; Petrovsky N; Salunke DB
Eur J Med Chem; 2024 May; 271():116439. PubMed ID: 38691886
[TBL] [Abstract][Full Text] [Related]
2. Further Insights on Structural Modifications of Muramyl Dipeptides to Study the Human NOD2 Stimulating Activity.
Cheng WC; You TY; Teo ZZ; Sayyad AA; Maharana J; Guo CW; Liang PH; Lin CS; Meng FC
Chem Asian J; 2020 Nov; 15(22):3836-3844. PubMed ID: 32975372
[TBL] [Abstract][Full Text] [Related]
3. Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFκB and NOD2-EGFR.
Juárez-Verdayes MA; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
Graefes Arch Clin Exp Ophthalmol; 2013 Jan; 251(1):53-62. PubMed ID: 22890731
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation.
Stafford CA; Gassauer AM; de Oliveira Mann CC; Tanzer MC; Fessler E; Wefers B; Nagl D; Kuut G; Sulek K; Vasilopoulou C; Schwojer SJ; Wiest A; Pfautsch MK; Wurst W; Yabal M; Fröhlich T; Mann M; Gisch N; Jae LT; Hornung V
Nature; 2022 Sep; 609(7927):590-596. PubMed ID: 36002575
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of biologically active biotinylated muramyl dipeptides.
Grimes CL; Podolsky DK; O'Shea EK
Bioorg Med Chem Lett; 2010 Oct; 20(20):6061-3. PubMed ID: 20822907
[TBL] [Abstract][Full Text] [Related]
6. Membrane targeting enhances muramyl dipeptide binding to NOD2 and Arf6-GTPase in mammalian cells.
Hespen CW; Zhao X; Hang HC
Chem Commun (Camb); 2022 Jun; 58(46):6598-6601. PubMed ID: 35584401
[TBL] [Abstract][Full Text] [Related]
7. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
[TBL] [Abstract][Full Text] [Related]
8. Lipophilic Muramyl Dipeptide-Antigen Conjugates as Immunostimulating Agents.
Willems MM; Zom GG; Meeuwenoord N; Khan S; Ossendorp F; Overkleeft HS; van der Marel GA; Filippov DV; Codée JD
ChemMedChem; 2016 Jan; 11(2):190-8. PubMed ID: 26059481
[TBL] [Abstract][Full Text] [Related]
9. Identification of MDP (muramyl dipeptide)-binding key domains in NOD2 (nucleotide-binding and oligomerization domain-2) receptor of Labeo rohita.
Maharana J; Swain B; Sahoo BR; Dikhit MR; Basu M; Mahapatra AS; Jayasankar P; Samanta M
Fish Physiol Biochem; 2013 Aug; 39(4):1007-23. PubMed ID: 23255217
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory properties of novel nucleotide oligomerization domain 2 (nod2) agonistic desmuramyldipeptides.
Jakopin Ž; Gobec M; Mlinarič-Raščan I; Sollner Dolenc M
J Med Chem; 2012 Jul; 55(14):6478-88. PubMed ID: 22716113
[TBL] [Abstract][Full Text] [Related]
11. Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.
Coulombe F; Fiola S; Akira S; Cormier Y; Gosselin J
PLoS One; 2012; 7(5):e36734. PubMed ID: 22590599
[TBL] [Abstract][Full Text] [Related]
12. Freund's adjuvant, NOD2 and mycobacteria.
Behr MA; Divangahi M
Curr Opin Microbiol; 2015 Feb; 23():126-32. PubMed ID: 25483349
[TBL] [Abstract][Full Text] [Related]
13. Computational studies on receptor-ligand interactions between novel buffalo (Bubalus bubalis) nucleotide-binding oligomerization domain-containing protein 2 (NOD2) variants and muramyl dipeptide (MDP).
Brahma B; Patra MC; Mishra P; De BC; Kumar S; Maharana J; Vats A; Ahlawat S; Datta TK; De S
J Mol Graph Model; 2016 Apr; 65():15-26. PubMed ID: 26897084
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Diverse N-Substituted Muramyl Dipeptide Derivatives and Their Use in a Study of Human NOD2 Stimulation Activity.
Chen KT; Huang DY; Chiu CH; Lin WW; Liang PH; Cheng WC
Chemistry; 2015 Aug; 21(34):11984-8. PubMed ID: 26226896
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into the MDP binding and CARD-CARD interaction in zebrafish (Danio rerio) NOD2: a molecular dynamics approach.
Maharana J; Patra MC; De BC; Sahoo BR; Behera BK; De S; Pradhan SK
J Mol Recognit; 2014 May; 27(5):260-75. PubMed ID: 24700593
[TBL] [Abstract][Full Text] [Related]
16. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
17. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
Hedl M; Abraham C
J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
[TBL] [Abstract][Full Text] [Related]
18. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
Coulombe F; Divangahi M; Veyrier F; de Léséleuc L; Gleason JL; Yang Y; Kelliher MA; Pandey AK; Sassetti CM; Reed MB; Behr MA
J Exp Med; 2009 Aug; 206(8):1709-16. PubMed ID: 19581406
[TBL] [Abstract][Full Text] [Related]
19. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA
J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel 2-azido muramyl dipeptide as NOD2 agonistic adjuvants.
Reddy PRS; Sambyal S; Mhamane TB; Sravanthi V; Shafi S; Khan IA; Sampath Kumar HM
Bioorg Med Chem; 2022 Jul; 66():116781. PubMed ID: 35569249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
